Understanding where retatrutide stands requires understanding what makes it mechanistically distinct from its predecessors, where Phase 3 trials currently sit, what a realistic regulatory timeline looks like, and what options exist for patients who cannot or do not want to wait
While IPL represents a significant investment, many patients find the long-term benefits justify the cost when compared to ongoing expenses for topical medications, makeup to cover redness, and the emotional impact of untreated rosacea
Ipamorelin is a growth hormone-releasing peptide (GHRP) a completely different class
References Chew, BP, Park, JS, Wong, TS, Kim, HW, Weng, BBC, Bryne, KM, Hayek, MG, Reinhart, GA